jte 522 has been researched along with Adenomatous Polyposis Coli in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akasu, T; Iwama, T; Muto, T; Utsunomiya, J | 1 |
| Masaki, M; Sasai, H; Wakitani, K | 1 |
1 trial(s) available for jte 522 and Adenomatous Polyposis Coli
| Article | Year |
|---|---|
Does a selective cyclooxygenase-2 inhibitor (tiracoxib) induce clinically sufficient suppression of adenomas in patients with familial adenomatous polyposis? A randomized double-blind placebo-controlled clinical trial.
Topics: Adenomatous Polyposis Coli; Adult; Colonic Polyps; Cyclooxygenase 2 Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Organic Chemicals | 2006 |
1 other study(ies) available for jte 522 and Adenomatous Polyposis Coli
| Article | Year |
|---|---|
Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522.
Topics: Adenomatous Polyposis Coli; Amino Acid Sequence; Animals; Base Sequence; Benzenesulfonates; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Genes, APC; Genotype; Isoenzymes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Mutation; Oxazoles; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction | 2000 |